Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
(NASDAQ: XENE) Delayed: 54.61 -0.18 (0.33%)
Previous Close $54.79    52 Week High $9.75 
Open $54.62    52 Week Low $5.65 
Day High $55.47    P/E N/A 
Day Low $54.12    EPS $0.00 
Volume 1,498,297       

(NASDAQ: XENE) Delayed: 54.61 -0.18 (0.33%)
Previous Close $54.79    52 Week High $9.75 
Open $54.62    52 Week Low $5.65 
Day High $55.47    P/E N/A 
Day Low $54.12    EPS $0.00 
Volume 1,498,297